Medicine supply in emerging markets: Africa
We respect your privacy, by submitting this form you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest. For further information on how we process and monitor your personal data click here.
Access to medicines in Africa is in need of vast improvement.
At a recent industry conference it was highlighted that annually millions of preventable deaths exist due to lack of adequate vaccine supply. Individuals may have to walk large distances to reach healthcare institutions. There is no guarantee that this clinic is going to stock the medicine needed or have the member of staff available to support the individual.
Africa’s predicted growth to 2020 is projected to be driven by swift urbanisation, with a growing middle class. However, there is a forecasted increase of lifestyle diseases such as cancer and diabetes. Also there will be the inevitable combat against infectious diseases perpetuated by the region’s tropical habitat.
Medicines in Africa
Africa has experienced large jumps in the size of its pharmaceutical industry with 2013 seeing a $15 billion increase on the year prior. Public-private health partnerships are predicted to rise in frequency.
To successfully supply medicines in this continent, market authorisation holders must equip themselves with the local expertise of Africa's landscape in terms of its infrastructure, regulatory climate, weather and population forecasts.
Download this infographic to explore the key elements impacting pharmaceutical supply chains running through Africa
Stay tuned for part three of this infographic series looking at Latin America.